SABS - Total Utang marang Modal SAB Biotherapeutics Inc

Logo perusahaan publik SAB Biotherapeutics (SABS)

SAB Biotherapeutics maintains an impeccable reputation for developing human antibodies via transgenic animals, as evidenced by the price chart on GURU.Markets, where the indicator stands at 0.02. The business relies on precise plasma transportation, ensuring resource preservation and high profitability. Additionally, SAB Biotherapeutics implements ethical animal treatment and advanced bio-waste filtration, adhering to strict environmental standards.

SABS: Total Utang marang Modal SAB Biotherapeutics, Inc. 04.07.2022 - 29.10.2026

Rincian analitis perusahaan SAB Biotherapeutics

- rega lan prakiraan konsensus rega:
Bagan rega SAB Biotherapeutics, Inc.|SABS - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar SAB Biotherapeutics|SABS - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham SAB Biotherapeutics|SABS - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku sabbiotherapeutics.com|SABS - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas SAB Biotherapeutics|SABS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal SAB Biotherapeutics|SABS - Gunggung utang perusahaan|Utang marang nilai buku SAB Biotherapeutics|SABS - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan SAB Biotherapeutics
Analisis dhasar perusahaan:SAB Biotherapeutics, Inc.
Barang utama SAB Biotherapeutics Inc

This ratio measures the degree of financial leverage by comparing total liabilities to net assets to assess the business's dependence on borrowed capital. An analysis of the total debt-to-equity ratio confirms that the low leverage of SAB Biotherapeutics (SABS), combined with the monopoly status of the DiversitAb platform and inelastic demand for its drugs, minimizes bankruptcy risk and enhances the company's overall investment stability.

Analisis pesaing SAB Biotherapeutics

Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|PVLA - Utang marang Ekuitas|Koefisien Total Utang marang Modal Savara Pharma SVRA|RIGL: Total Utang marang Modal|anaptysbio.com (ANAB) - Total Utang marang Modal|ATXS (Astria Therapeutics, Inc.) - Total Utang marang Modal|Utang marang Ekuitas ENGN|Rasio Total Utang marang Ekuitas RAPT (RAPT Therapeutics, Inc.)|JBIO (aerovatetx.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ACRS (Aclaris Therapeutics)|kyvernatx.com - Utang marang Ekuitas|Tiziana Life Sciences Ltd - Total Utang marang Modal|Koefisien Total Utang marang Modal Cabaletta Bio Inc. CABA|Ventyx Bio (VTYX) - Utang marang Ekuitas|Utang marang Modal Theratechnologies, Inc (THTX)|Rasio Total Utang marang Ekuitas AVTX|ELDN (eledon.com) - Utang Agregat marang Modal|Total Utang marang Modal AGEN|CLYM (Climb Bio Inc.) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ZURA (Zura Bio Limited)|aTyr Pharmaceuticals (ATYR) - Utang marang Modal|ADAG - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi IMA (ImageneBio Inc)|STTK: Total Utang marang Modal|Equillium (EQ) - Total Utang marang Modal|Utang marang Ekuitas Connect Biopharma Holdings|Immunic Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal ATRA|IFRX - Utang marang Modal|X4 Pharmaceuticals, Inc. - Rasio Total Utang marang Ekuitas|Total Utang marang Modal Adicet Bio Inc. ACET|CELU: Rasio Total Utang marang Ekuitas|INmune Bio Corporation - Utang Agregat marang Modal|BRNS: Total Utang marang Modal|KZR - Koefisien Total Utang marang Modal|AKTX (Akari Therapeutics Plc) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Enlivex Therapeutics, Ltd. (ENLV)|Utang marang Ekuitas Q32 Bio Inc. (QTTB)|Koefisien Total Utang marang Modal GeoVax Corp|Utang marang Ekuitas Edesa Biotech, Inc. EDSA|Koefisien Total Utang marang Modal ibioinc.com (IBIO)|Carisma Tx - Total Utang marang Modal|XTLB - Total Utang marang Modal|BOLT: Total Utang marang Modal|HCWB (HCW Biologics) - Utang marang Ekuitas|Utang marang Ekuitas Aptevo Therapeutics, Inc.|AIM ImmunoTech, Inc. (AIM) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Aditxt (ADTX)|GRI: Utang Agregat marang Ekuitas|Total Utang marang Modal XRTX (XORTX)|Rasio Kabeh Utang marang Dana Pribadi HIND|Revelation Biosciences - Total Utang marang Modal|INDP - Total Utang marang Modal|Scinai Immunotherapeutics Ltd. (SCNI) - Utang marang Ekuitas|CalciMedica - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Affimed NV|Rasio Total Utang marang Ekuitas Allakos Therapeutics (ALLK)|Total Utang marang Modal HOOK|Total Utang marang Modal igmbio.com (IGMS)|iTeos Therapeutics, Inc. - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi OCEA|TC BioPharm (Holdings) PLC - Total Utang marang Modal|Koefisien Total Utang marang Modal Third Harmonic Bio Inc THRD